Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01994382
Title Phase 1 Dose Escalation Study in Chronic Lymphocytic Leukemia and Non-hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Portola Pharmaceuticals
Indications

diffuse large B-cell lymphoma

follicular lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

mantle cell lymphoma

lymphoplasmacytic lymphoma

Therapies

Cerdulatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.